ChromaDex Corporation Message Board

Frankenpiltch, what was your alias three days ago, Dan?

Agreed, I think $1+ comes at some point this summer, based on specualtion alone. The stock has a hard time not being tied strictly to it's value. Once that tie is broken, then it's market cap will be subjective and at the mercy of Frost and the more than ample financial management influence CDXC has already. Something is cooking, because a struggling company would not need to support financial related management as much as CDXC does. Lets hope those insiders know what they are doing.

Remembering one of Dan's threats about watching out for insiders: Why go against the insiders? Seriously, isn't being on the side of insiders exactly where you want to be? It is for me. I agree the stock is risky, but for me it is way better than trading options or futures, I can tell by the sleeps I get :)

To me, the potential for a home run with CDXC is real and worth waiting for through thick and thin. The last fairly firm base we tested was approx. $0.50 which makes this relatively safe for me. I'm still willing to bet anyone that we will see a dollar before we see $0.50 cents again. Why doesn't anyone take me up on the offer? because nobody bets against a sure thing - that's why.

Curious: I remember you have a fairly high break even point compared to me ($0.64), are you in it to get out with no loss or to make some money?

Wow, I thought they may have been targeting the "axon" market first, because of some of the most recent patents, but a full fledged "next generation vitamin B" sounds like a large scale release.

I can't see the ball any more, looks like it is on it's way out of the stadium.

Ladansha, I didn't even read your post because my brain wouldn't let me. Thank god, by the sounds of it. If you are trying to help me again, please don't. The best help you could give me is to worry about something other than CDXC. Can't you think of anything else? Maybe at least watch tv for a while, probably pick up on something else that bugs you pretty quickly. If you are getting paid to slam the stock, then you are worse than this long distance computer that calls my home every once in a while with no message.

Nice chart on WIN, looks ripe for entry - NOT. Go away and never come back.

"Nobody should ever be on the same side as an insider, that would be stupid."
Is that what Dan's point is?

Is Frank...'s concludsion that the blueberies are not profitable as he thought they should be so he is out? The blueberry comercialization was still profitable (albeit not as much as I would have hoped), and there will be sales of the raw product going forward which will only make it more profitable.

Why does anything other than NR matter anyways? The new caffine product should keep things oiled as we await NR.

I like the implications I feel when I read this. CDXC is going to bust out of the OTC BB wihtin my investment hozizon. The search for the holy grail is on, and no I do not weigh the same as a duck. :)

Me too. SPEX is up 33% on the news, but little action on CDXC? Something is out of place here, they have the ROR. One Day, CDXC is going to explode as the quality and quantity of it's products are realized. I feel better about their inventory than my u.to uranium holdings :)

Ha, everyone except wm.wagner has realized this relatively quickly. At least they shoot themselves in the foot eventually so hopefully nobody really get's tricked by them. The best part of their stroy is that they would have us believe that they are worried about the poor longs of CDXC. There are a lot of other stocks out there to be more worried about, so why do they pick CDXC? Ex-employees is the best recent guess I have heard.

Good call, looks like some nice buying today. Market makers seem reluctant to let it thorugh $0.70, their reluctance could backfire if the next earnings are released, then we could be in for a spike.

What's to figure out? Any price under 2 bucks is irrelavent, in that the company has not caught on yet, obviously. I'm fine with it floating around in a range, if at some point this year the company becomes profitable. What price would Frost sell at or his buddies is more of a concern (upside price that is). Their is no downside price Frost would sell at we all know that (I.e as zero would be reached the same day he started selling). I'm all or nothing like Frost on this one. With all the financial focus cdxc has I bet they find a way to create some significant value.

How is thinking that CDXC's new products as being a positive influence on the world translate into pimping the shares? How can you think what CDXC creates is not good for the world? If you truely believe they are bad why on earth would you pick CDXC to #$%$ and complain about? Why not pick McDonalds, or any other company producing #$%$ that CDXC is trying to counter. You should look into buying a book on logic.

I agree with all of your comments! Especially if the cafinated concept catches on. Nice to have another product that could be huge - good point!

The Merck study had nothing to do with an ingredient found in milk. All fruit is not alike, apples are different from oranges. The chemical makeup is different, whether they react with the same receptors is irrelavent as different chemicals react differently with the same receptors, always, by definition. The point is, the molecular structure of what Merck had is different from what CDXC has. Your trying to say that difference does not matter, I'm trying to say that difference is all that matters. These differences allow for difference reactions and results. Very small changes produce completely different results.

Luckily Frank released his latest comments about NR well after the Merck findings. In which I quote the last sentence on the earnings release March 29th: "Moreover, we were able to acquire what we believe is the most relevant and valuable IP pertaining to the commercialization of nicotinamide riboside, an ingredient that may prove to be one of the best opportunities yet for ChromaDex to create shareholder value."

This sentence effectively being the conclusion of the earnings release must be significant to CDXC. How can CDXC obviously not care about the Merck study since the Merck study was reported significantly earlier than the latest earnings release? To me, this means either CDXC is wrong or you are wrong (I.e. when it comes to whether the Merck study has any relation to CDXC). I don't believe CDXC is living in a bubble especially considering how many boards they are a part of these days. I.e. Something as important as what you make it sound like would not just miss their radar would it? I guess they should start reading your comments, eh Sharon.

Nice try, the thumbs have decided - time to try peddling doom and gloom elsewhere.